Rheumatoid Arthritis (RA)NCT07878611
Musclockeletal Ultra-sound Assessment of Pulley Inflammation in Rheumatoid Arthrits Pateints
An observational study of Rheumatoid Arthritis (RA), run by Sohag University.
Trial summary
assessment of pulley inflammation in rheumatoid arthrits patients using muscloskeletal ultra-sound Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Rheumatoid Arthritis (RA)
- How many people
- 80 participants
- Where
- No sites listed yet
- Study dates
- Sep 2026to Sep 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Group I: 30 patients with early rheumatoid arthritis. Group II: 30 individuals at risk of rheumatoid arthritis. Group III: 20 healthy age- and sex-matched controls who will be recruited from Rheumatology and Rehabilitation department at Sohag university hospital, 30 of them Early rheumatoid arthritis patients diagnosed according to the 2010 ACR/EULAR criteria with disease duration less or within 1 year, and 30 of them Individuals with clinically suspect arthralgia and positive RF and/or anti-CCP antibodies without clinical evidence of synovitis , and 20 of them Healthy age- and sex-matched controls without rheumatologic disease.
Who may be able to join
- • Group I:
- Age ≥18 years •
- Early RA diagnosed according to 2010 ACR/EULAR criteria •
- Disease duration <1 year
- B-Group II:
- Arthralgia without clinical arthritis •
Show all 10Show fewer
- Positive RF and/or anti-CCP antibodies •
- Age ≥18 years
- C-Group III:
- • Healthy adults without inflammatory rheumatic disease
Who cannot join
- • Psoriatic arthritis
- Gout or crystal arthropathy
- Systemic lupus erythematosus
- Active infection
- Pregnancy
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Ultrasound-detected Pulley Inflammation Across the Rheumatoid Arhritis Continuum: Across Sectional Study
assessment of pulley inflammation in rheumatoid arthrits patients using muscloskeletal ultra-sound
- Conditions
- Rheumatoid Arthritis (RA)
- Medical subject headings
- Arthritis, Rheumatoid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Group I: 30 patients with early rheumatoid arthritis. Group II: 30 individuals at risk of rheumatoid | group 1 : 30 of them Early rheumatoid arthritis patients diagnosed according to the 2010 ACR/EULAR criteria with disease duration less or within 1 year, andgroup 2 : 30 of them Individuals with clinically suspect arthralgia and positive RF and/or anti-CCP antibodies without clinical evidence of synovitis , and group 3 : 20 of them Healthy age- and sex-matched controls without rheumatologic disease. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of Flexor Tendon Pulley Inflammation on Musculoskeletal Ultrasound
Comparison of the prevalence of flexor tendon pulley inflammation detected by musculoskeletal ultrasound among patients with rheumatoid arthritis, individuals at risk of developing rheumatoid arthritis, and healthy controls
Measured: 6 months to 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2026
- Study startSep 2026 (estimated)
- Primary completionMar 2027 (estimated)
- Study completionSep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rheumatoid Arthritis (RA)Studies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yara Osama Elsayed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07878611
- Sponsor's protocol ID
- soh-med-26-7-27MS
- Status last verified
- Oct 2026
- First submitted
- 31 Aug 2026
- Last updated
- 16 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrasound-detected Pulley Inflammation Across the Rheumatoid Arhritis Continuum: Across Sectional Study
- ClinicalTrials.gov ID
- NCT07878611
- Acronym / sponsor ID
- soh-med-26-7-27MS
- Conditions
- Rheumatoid Arthritis (RA)
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- Sep 2026 (estimated)
- Primary completion
- Mar 2027 (estimated)
- Study completion
- Sep 2027 (estimated)
- First posted
- 16 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
assessment of pulley inflammation in rheumatoid arthrits patients using muscloskeletal ultra-sound
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group I: 30 patients with early rheumatoid arthritis. Group II: 30 individuals at risk of rheumatoid | – | –group 1 : 30 of them Early rheumatoid arthritis patients diagnosed according to the 2010 ACR/EULAR criteria with disease duration less or within 1 year, andgroup 2 : 30 of them Individuals with clinically suspect arthralgia and positive RF and/or anti-CCP antibodies without clinical evidence of synovitis , and group 3 : 20 of them Healthy age- and sex-matched controls without rheumatologic disease. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Group I: 30 patients with early rheumatoid arthritis. Group II: 30 individuals at risk of rheumatoid arthritis. Group III: 20 healthy age- and sex-matched controls who will be recruited from Rheumatology and Rehabilitation department at Sohag university hospital, 30 of them Early rheumatoid arthritis patients diagnosed according to the 2010 ACR/EULAR criteria with disease duration less or within 1 year, and 30 of them Individuals with clinically suspect arthralgia and positive RF and/or anti-CCP antibodies without clinical evidence of synovitis , and 20 of them Healthy age- and sex-matched controls without rheumatologic disease.
Key inclusion criteria (10 listed)
- • Group I:
Key exclusion criteria (5 listed)
- • Psoriatic arthritis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of Flexor Tendon Pulley Inflammation on Musculoskeletal Ultrasound
Time frame: 6 months to 1 year
Comparison of the prevalence of flexor tendon pulley inflammation detected by musculoskeletal ultrasound among patients with rheumatoid arthritis, individuals at risk of developing rheumatoid arthritis, and healthy controls
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2026.
Related trials for Rheumatoid Arthritis (RA)
Not yet recruitingPhase 1
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
Rheumatoid Arthritis and Systemic Lupus Erythematosus
Active, not recruitingObservational study
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Recruiting
GenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection
Rheumatoid Arthritis
Not yet recruitingObservational study
The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development of Lung Cancer
Rheumatoid Arthritis (RA), Lung Neoplasms
Not yet recruiting
MYTP01 for Immune-Mediated Diseases
IgA Nephropathy, Kidney Transplant Recipients
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Rheumatoid Arthritis (RA), run by Sohag University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact yara osama yara osama (01010706484, yara.osama303030@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of Flexor Tendon Pulley Inflammation on Musculoskeletal Ultrasound (time frame: 6 months to 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.